Get the Stockscreener App
427.20
2.42%
-10.58
After Hours:
427.20
Medpace Holdings Inc stock is traded at $427.20, with a volume of 504.39K.
It is down -2.42% in the last 24 hours and up +36.11% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$437.78
Open:
$435.52
24h Volume:
504.39K
Relative Volume:
1.06
Market Cap:
$12.00B
Revenue:
$2.16B
Net Income/Loss:
$416.39M
P/E Ratio:
32.61
EPS:
13.1
Net Cash Flow:
$540.93M
1W Performance:
-6.25%
1M Performance:
+36.11%
6M Performance:
+22.35%
1Y Performance:
+11.68%
1-Day Range:
$426.48
$440.00
1-Week Range:
$426.48
$455.15
52-Week Range:
$250.05
$501.30
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
427.20 | 12.30B | 2.16B | 416.39M | 540.93M | 13.10 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Should I hold or sell Medpace Holdings Inc. stock in 2025Best Dividend Tips From AI Tools - jammulinksnews.com
Should You Buy Medpace (MEDP) After Golden Cross? - Zacks Investment Research
How does Medpace Holdings Inc. generate profit in a changing economyChart Pattern Planner With Low Risk - jammulinksnews.com
Have Medpace Holdings Insiders Been Selling Stock? - 富途牛牛
Medpace slips as UBS cuts to Sell despite strong Q2 results - MSN
How Medpace Holdings Inc. stock performs during market volatilityShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Institutional Tools Highlight Unusual Flow in Medpace Holdings Inc.Swing Trading Plan With Smart Signals in Review - metal.it
Medpace general counsel Ewald sells $1.35m in stock - Investing.com
Medpace general counsel Ewald sells $1.35m in stock By Investing.com - Investing.com Nigeria
Insider Selling at Medpace Holdings: Distinguishing Routine Moves from Red Flags - AInvest
Medpace stock slips as UBS cuts to Sell (MEDP:NASDAQ) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - Yahoo Finance
What makes Medpace Holdings Inc. stock price move sharplyCommunity Shared Smart Money Signals Show Movement - metal.it
Medpace stock rating downgraded to Sell by UBS on ambitious targets - Investing.com
Decoding Insider Selling at Medpace Holdings: A Strategic Investment Analysis - AInvest
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Yahoo Finance
What Makes Medpace (MEDP) a New Strong Buy Stock - sharewise.com
Best Momentum Stocks to Buy for July 28th - TradingView
Is Medpace Holdings Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com
New Strong Buy Stocks for July 28th - TradingView
Why is Medpace Holdings Inc. stock attracting strong analyst attentionBest Dividend Forecasts To Watch Now - jammulinksnews.com
Medpace Holdings, Inc. Reports Strong Q2 Earnings and Market ResponseNews and Statistics - IndexBox
Top 10 Large Cap Gainers Last Week: Medpace, Baker Hughes, and More - AInvest
5 Revealing Analyst Questions From Medpace’s Q2 Earnings Call - Yahoo Finance
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Why Medpace Holdings Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - metal.it
Mizuho Securities Maintains Buy Rating on Medpace Holdings with $510 Price Target. - AInvest
Medpace Is Expanding Decentralized Clinical Trials & Improving Global Trial Capabilities But Is It ENOUGH? - Smartkarma
Medpace Holdings, Inc. (MEDP): A Bull Case Theory - Insider Monkey
Medpace Holdings, Inc. shares rise 1.01% after-hours after reporting numbers well above expectations. - AInvest
What drives Medpace Holdings Inc. stock priceOutstanding capital returns - PrintWeekIndia
Medpace Holdings (MEDP) Receives Price Target Boost from Mizuho | MEDP Stock News - GuruFocus
Medpace (MEDP) Target Price Boosted by Mizuho to $510 | MEDP Sto - GuruFocus
Stocks making big moves this week: Cal-Maine, Skillz, TransUnion, Medpace, and Bruker - Yahoo Finance
What analysts say about Medpace Holdings Inc. stockOutstanding growth strategies - Autocar Professional
Medpace Holdings Trading Volume Plummets 49.44 Percent to 285th Position Despite 4.18 Percent Stock Price Increase - AInvest
Medpace Holdings, Inc. Beat Revenue Forecasts By 12%: Here's What Analysts Are Forecasting Next - 富途牛牛
Medpace Holdings Reports Strong Q2 2025 Growth - The Globe and Mail
Medpace Holdings Plummets to 140th in Trading Volume Ranking Amid 61.52% Decline - AInvest
Medpace raises 2025 revenue guidance to $2.42B–$2.52B amid strong backlog conversion and lower cancellations - MSN
Medpace Stock Downgraded by TD Cowen After Significant RallyNews and Statistics - IndexBox
UBS Sticks to Its Hold Rating for Medpace Holdings (MEDP) - The Globe and Mail
Medpace (MEDP) Stock Trades Down, Here Is Why - Yahoo Finance
MEDP: Truist Securities Raises Medpace Holdings Price Target to - GuruFocus
Why Medpace Holdings Shares Are Facing Turbulence - TipRanks
Narrow-Moat Medpace Benefits From Rising Outsourcing Demand and Shift Toward Faster-Burning Studies - Morningstar
Baird Raises Price Target for Medpace Holdings (MEDP) to $490 | - GuruFocus
Barclays Raises Price Target for Medpace Holdings (MEDP) to $450 - GuruFocus
Medpace Holdings: Baird maintains a 'Neutral' Rating, The Target Price is $490 - AInvest
Medpace Holdings' (MEDP) 50% Stock Surge: A Deep Dive into Q2 Earnings and Strategic Growth Drivers - AInvest
Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta - Yahoo Finance
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):